199 related articles for article (PubMed ID: 36720520)
1. Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer.
Byun JM; Cho HJ; Lee DS; Yoon HK; Kim YN; Im DH; Kim DH; Lee KB; Sung MS; Jeong DH
Taiwan J Obstet Gynecol; 2023 Jan; 62(1):107-111. PubMed ID: 36720520
[TBL] [Abstract][Full Text] [Related]
2. Outcome and Management of Serous Tubal Intraepithelial Carcinoma Following Opportunistic Salpingectomy: Systematic Review and Meta-Analysis.
Ruel-Laliberté J; Kasasni SM; Oprea D; Viau M
J Obstet Gynaecol Can; 2022 Nov; 44(11):1174-1180. PubMed ID: 36099965
[TBL] [Abstract][Full Text] [Related]
3. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
[TBL] [Abstract][Full Text] [Related]
4. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
Cass I; Walts AE; Barbuto D; Lester J; Karlan B
Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639
[TBL] [Abstract][Full Text] [Related]
5. Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Eckert MA; Pan S; Hernandez KM; Loth RM; Andrade J; Volchenboum SL; Faber P; Montag A; Lastra R; Peter ME; Yamada SD; Lengyel E
Cancer Discov; 2016 Dec; 6(12):1342-1351. PubMed ID: 27856443
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.
Chay WY; McCluggage WG; Lee CH; Köbel M; Irving J; Millar J; Gilks CB; Tinker AV
Int J Gynecol Cancer; 2016 Mar; 26(3):431-6. PubMed ID: 26807643
[TBL] [Abstract][Full Text] [Related]
7. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
Seidman JD
Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178
[TBL] [Abstract][Full Text] [Related]
8. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
9. Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
Stanciu PI; Ind TEJ; Barton DPJ; Butler JB; Vroobel KM; Attygalle AD; Nobbenhuis MAE
J Ovarian Res; 2019 May; 12(1):50. PubMed ID: 31128592
[TBL] [Abstract][Full Text] [Related]
10. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
Patrono MG; Iniesta MD; Malpica A; Lu KH; Fernandez RO; Salvo G; Ramirez PT
Gynecol Oncol; 2015 Dec; 139(3):568-72. PubMed ID: 26407480
[TBL] [Abstract][Full Text] [Related]
12. The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
Toptas T; Pestereli E; Simsek T; Bozkurt S; Erdogan G; Karaveli S
J Cancer Res Ther; 2018; 14(3):587-592. PubMed ID: 29893323
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.
Pölcher M; Hauptmann S; Fotopoulou C; Schmalfeldt B; Meinhold-Heerlein I; Mustea A; Runnebaum I; Sehouli J
Arch Gynecol Obstet; 2015 Jul; 292(1):231-4. PubMed ID: 25914073
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
[TBL] [Abstract][Full Text] [Related]
15. [Fallopian tube: the dark face of pelvic carcinogenesis].
Watkin E; Devouassoux-Shisheboran M
Ann Pathol; 2011 Oct; 31(5):345-52. PubMed ID: 21982240
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.
Dietl J
Arch Gynecol Obstet; 2014 Feb; 289(2):241-6. PubMed ID: 24100801
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation.
Abay M; Ozgen L; Yalcin Y; Ozerkan K
J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102642. PubMed ID: 37573025
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for diagnosing STIC: a systematic review and meta-analysis.
Bogaerts JMA; Steenbeek MP; van Bommel MHD; Bulten J; van der Laak JAWM; de Hullu JA; Simons M
Virchows Arch; 2022 Apr; 480(4):725-737. PubMed ID: 34850262
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Saccardi C; Zovato S; Spagnol G; Bonaldo G; Marchetti M; Alessandrini L; Tognazzo S; Guerriero A; Vitagliano A; Laganà AS; Noventa M
Gynecol Oncol; 2021 Nov; 163(2):364-370. PubMed ID: 34465478
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
Howitt BE; Hanamornroongruang S; Lin DI; Conner JE; Schulte S; Horowitz N; Crum CP; Meserve EE
Am J Surg Pathol; 2015 Mar; 39(3):287-93. PubMed ID: 25581732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
